Insights into Ready-to-Use Packaging Solutions for Injectables
On Wednesday Nov. 6, 2019, Gregor Deutschle and Dr. Nicolas Eon, both from Schott, will share insights into ready-to-use solutions for complex biotech drugs.
On Wednesday Nov. 6, 2019, Gregor Deutschle (director business development sterile solutions, Schott Pharmaceutical Systems) and Dr. Nicolas Eon (senior global product manager, Schott) will share insights into ready-to-use solutions for complex biotech drugs.
With the advent of highly complex biologics, personalized medicines, along with cell and gene therapies, there is a growing requirement for greater efficiency, flexibility, and simplicity in the manufacturing process of injectables. In the presentation, Deutschle and Eon will use the example of Schott’s iQ ready-to-use platform to provide insights into how universal containers can benefit manufacturers compared with bulk ones and provide quicker and simpler drug development, manufacture, and delivery.
Ready-to-Use Packaging Solutions to Transform Injectable Drug ManufacturingWednesday Nov. 6, 2019 16:30–17:00 InnoPack & P-MEC Theatre (110D50)
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
PostEra Expands Pfizer Partnership with AI Lab and ADC Collaborations
January 8th 2025The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.
